Skip to main content
Clinical Trials/NL-OMON50365
NL-OMON50365
Completed
N/A

eurological signs in very high-risk infants and developmental outcome at school age - Early neurological signs and outcome

niversitair Medisch Centrum Groningen0 sites68 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
cerebral palsy
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
68
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • For the patients: participation in the LEARN2MOVE 0\-2years project (L2M; n\=43\).
  • Inclusion criteria for the original LEARN2MOVE 0\-2 years project were age zero
  • to nine months CA at enrolment and the presence of at least one of the
  • following conditions:
  • (1\) cystic periventricular leukomalacia,
  • (2\) parenchymal lesion of the brain,
  • (3\) severe neonatal hypoxic\-ischaemic encephalopathy with brain lesions on MRI,
  • (4\) neurological dysfunctions suggestive of the development of CP.
  • For the control group:
  • (1\) typically developing

Exclusion Criteria

  • For the patients: Exclusion criteria of the LEARN2MOVE 0\-2 years project were:
  • \- Children with severe congenital disorders
  • \- Caregivers having insufficient understanding of the Dutch language
  • For the controls:
  • \- presence of a complicated neonatal history
  • \- presence of a neurodevelopmental disorder, such as cerebral palsy,
  • developmental coordination disorder, autism spectrum disorder, learning
  • disability, or attention deficit hyperactivity disorder
  • \- Presence of the complex form of minor neurological dysfunction (MND)
  • \- Caregivers having insufficient understanding of the Dutch language

Outcomes

Primary Outcomes

Not specified

Similar Trials